Related Experiment Video
Updated: Nov 11, 2025
03:53
An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
181
Neurosarcoidosis - a patient series
Summary
Neurosarcoidosis, a rare nervous system disorder, was studied in 17 patients. Most patients showed symptom improvement with corticosteroid therapy and immunotherapy, highlighting effective treatment strategies for this condition.
Area of Science:
- Neurology
- Immunology
- Rare Diseases
Background:
- Neurosarcoidosis is a rare inflammatory disease affecting the nervous system.
- It presents with diverse clinical manifestations impacting both central and peripheral nerves.
Purpose of the Study:
- To survey clinical manifestations of neurosarcoidosis.
- To review diagnostic assessment findings.
- To evaluate treatment strategies for neurosarcoidosis patients.
Main Methods:
- Retrospective assessment of 17 patients diagnosed between 2008-2019.
- Utilized contrast-enhanced MRI, PET, CT scans, and cerebrospinal fluid analysis.
- Biopsy was performed for definitive diagnosis when feasible.
Main Results:
- Central nervous system affection, hydrocephalus, and cranial neuropathy were common presentations.
- Imaging revealed sarcoidosis-like findings in most patients (MRI: 14/17, PET: 7/8, CT: 12/16).
- Cerebrospinal fluid abnormalities were present in all assessed patients (15/15), with 13/15 biopsies confirming the diagnosis. Symptom improvement or stabilization was observed in 16/17 patients with immunotherapy.
Conclusions:
- Neurosarcoidosis diagnosis relies on cerebrospinal fluid analysis and contrast-enhanced MRI.
- While biopsy is definitive, it's not always feasible; PET aids in assessment and biopsy site localization.
- Corticosteroids and immunotherapy demonstrate good treatment response in neurosarcoidosis.
